US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals Sept 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several US-listed companies, including Allstate, Autozone and Vertex Pharmaceuticals, on Wednesday.
HIGHLIGHTS
* Allstate Corp ALL.N: TD Cowen raises target price to $260 from $231 |
* Autozone Inc AZO.N: D.A. Davidson cuts target price to $3,500 from $3,750 |
* Martin Marietta Materials, Inc. MLM.N: Jefferies cuts target price to $670 from $720 |
* Vertex Pharmaceuticals Inc VRTX.O: Jefferies raises target price to $640 from $633 |
* Vulcan Materials Co VMC.N: Jefferies cuts target price to $320 from $345 |
Following is a summary of research actions on US companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.
* Acadia Healthcare Company Inc ACHC.O: Leerink Partners raises PT to $33 from $30 |
* Allstate Corp ALL.N: TD Cowen raises target price to $260 from $231 |
* Ally Financial Inc ALLY.N: Truist Securities cuts target price to $50 from $51 |
* American Express Company AXP.N: Truist Securities cuts target price to $370 from $375 |
* Amgen Inc AMGN.O: Jefferies raises target price to $410 from $367 |
* Amneal Pharma AMRX.O: Oppenheimer initiates with outperform rating; price target $27 |
* Amrize AMRZ.N: Deutsche Bank cuts target price to $56 from $64 |
* Anaptysbio Inc ANAB.O: Leerink Partners cuts target price to $81 from $90 |
* Anixa Biosciences Inc ANIX.O: H.C. Wainwright cuts target price to $6 from $7 |
* Applied Digital Corp APLD.O: UBS initiates coverage with buy rating and target $38 |
* Ardent Health Inc ARDT.N: BMO initiates with market perform rating; target price $11 |
* Autozone Inc AZO.N: BMO cuts target price to $3,500 from $,4000 |
* Autozone Inc AZO.N: D.A. Davidson cuts target price to $3,500 from $3,750 |
* Autozone Inc AZO.N: Exane BNP Paribas cuts target price to $3,561 from $3,979 |
* Autozone Inc AZO.N: Roth MKM cuts target price to $3,850 from $4,023 |
* Autozone Inc AZO.N: TD Cowen cuts target price to $3,400 from $3,500 |
* Autozone Inc AZO.N: Truist Securities cuts target price to $3,648 from $3,817 |
* Bank7 Corp BSVN.O: KBW raises target price to $62 from $56 |
* Belden Inc BDC.N: Needham initiates coverage with buy rating; price target $140 |
* Carnival Corp CCL.N: Jefferies cuts target price to $33 from $35 |
* CBIZ Inc CBZ.N: William Blair cuts to market perform rating |
* Celldex Therapeutics Inc. CLDX.O: Leerink Partners raises target price to $88 from $70 |
* Cipher Digital Inc CIFR.O: UBS initiates coverage with buy rating and target price $23 |
* Citizens Financial CFG.N: Truist Securities cuts target price to $77 from $80 |
* Collegium Pharmaceutical COLL.O: Oppenheimer initiates with outperform rating; PT $50 |
* Community Health Systems CYH.N: BMO initiates coverage with market perform rating; PT $3 |
* Compass Therapeutics Inc CMPX.O: Guggenheim cuts target price to $4 from $8 |
* Compass Therapeutics Inc CMPX.O: Jefferies cuts target price to $3 from $8 |
* Compass Therapeutics Inc CMPX.O: Wedbush cuts target price to $1 from $5 |
* Compass Therapeutics Inc CMPX.O: Wedbush cuts to neutral from outperform |
* Constellation Brands Inc STZ.N: UBS cuts target price to $145 from $168 |
* Core Scientific Inc CORZ.O: UBS initiates coverage with buy rating and target price $24 |
* Coreweave Inc CRWV.O: UBS initiates coverage with buy rating and target price $120 |
* Cormedix Inc CRMD.O: Oppenheimer initiates with outperform rating; price target $15 |
* Cummins CMI.N: JP Morgan cuts target price to $600 from $690 |
* Dauch Corp DCH.N: Jefferies cuts to hold from buy; cuts target price to $7.10 from $8.25 |
* Fifth Third Bancorp FITB.N: Truist Securities cuts target price to $63 from $64 |
* Fox Corp FOXA.O: Moffettnathanson raises target price by $5 to $70 |
* GE Aerospace GE.N: Jefferies cuts target price to $435 from $455 |
* General Dynamics Corp GD.N: Bernstein cuts target price to $407 from $421 |
* Graphic Packaging Holding Company GPK.N: JP Morgan cuts target price to $11.50 from $12.50 |
* Graphic Packaging Holding Company GPK.N: JP Morgan raises to overweight from neutral |
* Guardian Pharmacy Services Inc GRDN.N: Keybanc initiates with overweight rating; PT $52 |
* HCA Healthcare, Inc. HCA.N: BMO initiates coverage with outperform rating; PT $495 |
* HII HII.N: Bernstein cuts target price to $327 from $341 |
* Huntington Bancshares Inc HBAN.O: Truist Securities cuts target price to $19 from $20 |
* Hut 8 Corp HUT.O: UBS initiates coverage with buy rating and target price $143 |
* Innoviva Inc INVA.O: Oppenheimer assumes coverage with outperform rating; target $35 |
* KB Home KBH.N: Barclays cuts target price to $49 from $57 |
* KB Home KBH.N: RBC cuts target price to $50 from $53 |
* KB Home KBH.N: Truist Securities cuts target price to $50 from $55 |
* Keycorp KEY.N: Truist Securities cuts target price to $23 from $24 |
* L3Harris Technologies, Inc. LHX.N: Bernstein cuts target price to $346 from $365 |
* M&T Bank Corporation MTB.N: Truist Securities cuts target price to $250 from $268 |
* Martin Marietta Materials, Inc. MLM.N: Jefferies cuts target price to $670 from $720 |
* Marvell Technology MRVL.O: Seaport Research Partners initiates with buy rating; PT $270 |
* Merck & Co Inc MRK.N: TD Cowen raises target price to $155 from $137 |
* Nektar Therapeutics NKTR.O: Wedbush cuts target price to $50 from $80 |
* Nike Inc NKE.N: Oppenheimer cuts target price to $52 from $60 |
* Northrop Grumman NOC.N: Bernstein cuts target price to $620 from $653 |
* Onsemi ON.O: Seaport Research Partners initiates coverage with buy rating; PT $100 |
* Pacira Biosciences Inc PCRX.O: Oppenheimer initiates with outperform rating; PT $32 |
* PG&E Corp PCG.N: UBS cuts target price to $14 from $19 |
* PG&E Corp PCG.N: UBS cuts to neutral from buy |
* Philip Morris International Inc PM.N: UBS raises target price to $193 from $182 |
* Regions Financial RF.N: Truist Securities cuts target price to $31 from $34 |
* Roku Inc ROKU.O: Moffettnathanson raises target price by $7 to $160 |
* RTX Corporation RTX.N: Bernstein cuts target price to $223 from $232 |
* Semtech Corp SMTC.O: Seaport Research Partners initiates with buy rating; target $200 |
* SiTime Corp SITM.O: Seaport Research Partners initiates coverage with neutral rating |
* Tenet Healthcare Corp THC.N: BMO initiates with market perform rating; target price $265 |
* Terawulf Inc WULF.O: UBS initiates coverage with buy rating and target price $24 |
* The Baldwin Insurance Group BWIN.O: Raymond James cuts to underperform from strong buy |
* The Toro Company TTC.N: Oppenheimer initiates coverage with outperform rating; PT $120 |
* Thor Industries Inc THO.N: Jefferies cuts target price to $82 from $90 |
* UiPath Inc PATH.N: RBC cuts target price to $15 from $17 |
* UiPath Inc PATH.N: Truist Securities cuts target price to $14 from $17 |
* UiPath Inc PATH.N: UBS cuts target price to $15 from $19 |
* Vanda Pharmaceuticals VNDA.O: Oppenheimer initiates with outperform rating; PT $10 |
* Vertex Pharmaceuticals Inc VRTX.O: Jefferies raises target price to $640 from $633 |
* Viatris Inc VTRS.O: Oppenheimer initiates with outperform rating; price target $25 |
* Viking Therapeutics Inc VKTX.O: Oppenheimer raises target price to $120 from $100 |
* Viking Therapeutics Inc VKTX.O: Truist Securities raises target price to $87 from $83 |
* Vulcan Materials Co VMC.N: Jefferies cuts target price to $320 from $345 |
* Weatherford International Plc WFRD.O: UBS cuts target price to $116 from $120 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Recent news on Celldex Therapeutics
See all newsUS RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
U.S. STOCKS ON THE MOVE-Greenland Mines, GameStop, Shopify
Celldex shares slip as safety concerns cloud skin drug trial win (updated)
Celldex falls after two probable anaphylaxis cases in trials
Celldex's skin disease drug meets goals in two late-stage trials